Basal-cell carcinoma
Basal-cell carcinoma (BCC), also known as basal-cell cancer, is the most common type of skin cancer that arises from the innermost layer of the skin. It typically appears as a painless raised area that may be shiny with small blood vessels or exhibit ulceration, grows slowly, and can damage surrounding tissue but is unlikely to spread to distant areas or be fatal.
Health Outcomes
- Enhanced DNA Repair
- Enhanced Photoprotection
- Improved Lesion Regression
- Improved Scar Appearance
- Increased Epithelial Proliferation
- No Change in Growth Metrics
- No Significant Change in Health Variables
- No Significant Effect on Anxiety Levels
- Reduced Actinic Damage
- Reduced Actinic Keratosis Count
- Reduced Cyclobutane Pyrimidine Dimer Level
- Reduced Nonmelanoma Skin Cancer Incidence
- Reduced Recurrence
- Reduced Risk of Non-Melanoma Skin Cancer
- Reduced Skin Cancer Progression
- Reduced Thymidine Dimer Level
- Reduced Topical Drug Application
- Reduced UVB-Induced Skin Cell Damage
- Reduced Ultraviolet Radiation-Induced DNA Damage
- Treated Actinic Keratoses
- Treated Basal Cell Carcinoma